Breast cancer surgery skipped in trial for patients who respond fully to drugs
Disease control
Terminated
This early study tested whether women with a certain type of low-risk HER2-positive breast cancer could safely skip surgery if their tumors disappeared completely after standard chemotherapy and anti-HER2 drugs. Only 5 women were enrolled before the study was stopped early. The g…
Phase: PHASE2 • Sponsor: Fundacio Clinic Barcelona • Aim: Disease control
Last updated May 01, 2026 15:57 UTC